Language Selection

Français

Rabies Serum Neutralization Assay

<<Return to Search Results

Accredited by the Standards Council of Canada to ISO/IEC 17025 (File no. 15734).

Requisition Forms

Reference Details

Description:

Serology for detection of neutralizing antibodies to rabies virus.

Test Category:
Serology
Pathogen:
Rabies virus
Illnesses and Diseases:
  • Rabies
Specimen:

Serum sample, cerebrospinal fluid (CSF). Minimum volume required – 2 mL.

Collection Method:

Submit in a sterile microcentrifuge tube.

Specimen Processing, Storage and Shipping:

Store samples refrigerated or frozen until shipped for testing. Ship frozen samples on dry ice, and refrigerated samples on wet ice

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Patient Criteria:

Individuals who have received pre- or post-exposure vaccination for rabies virus. The Rabies, Rickettsia and Related Zoonotic Diseases laboratory must be notified prior to the submission of any samples for clinical investigation.

Accompanying Documentation:

Completed Requisition for Serological Testing for Rabies requisition including sender name, address and telephone number. Patient name or identifier (referring lab #), date of birth, occupational category, vaccination history, administration of RIG, animal exposure, travel history. Type of specimen and date collected.

Comments:

Samples for post exposure vaccination will not be tested unless all requested information is supplied. The Vector-Borne and Zoonotic Diseases laboratory must be notified prior to the submission of any samples for clinical investigation.

Methods and Interpretation of Results:

Neutralizing antibody titres are reported in International Units/ml (IU/ml). Booster vaccination is recommended if antibody titre falls below 0.5 IU/ml. Individuals with antibody levels between 0.5 IU/ml and 1.0 IU/ml should be carefully assessed for their risk of exposure; if a booster dose of vaccine is not administered, a new serum sample should be drawn and tested within 3-6 months to ensure that the individual's antibody level does not fall below 0.5 IU/ml.

Turnaround Time:

30 calendar days.

Contact:
Phone #: (204) 789-7037
Fax: (204) 789-2018
References:
  1. Statement on travellers and rabies vaccine. Canada Communicable Disease Report. 2002; 28: 1-12.
Related Information: